Omay, Dallas T.

HRN: 22-76-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2023
CEFUROXIME 750MG (VIAL)
12/16/2023
12/22/2023
IV
250mg
Q8
AGE;URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: